Hydroxychloroquine-induced podocytopathy mimicking Fabry disease

Hydroxychloroquine (HCQ) is largely prescribed as an immunomodulator to prevent systemic diseases flares in patients with systemic lupus erythematous, rheumatoid arthritis, Sjogren’s disease. Among reported side effects, HCQ can accumulate in lysosomes and induced phospholipidosis. Here, we report a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Serre, Justine, Buob, David, Boffa, Jean-Jacques
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536225/
https://ncbi.nlm.nih.gov/pubmed/31088818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228876
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak